Scenarios that move BSX
Boston Scientific Corporation Common Stock
Scenarios that move BSX: 6 analyses, 4 positive, 2 negative.
- · FDA expands ImmunityBio's Anktiva label for bladder cancer — ▲ · impact +25 · confidence low · horizon quarters
- · J&J beats Q3 earnings estimates, misses sales and raises outlook — ▲ · impact +40 · confidence low · horizon weeks
- · UnitedHealth tops estimates, raises profit outlook despite high medical costs — ▲ · impact +48 · confidence low · horizon quarters
- · BDX expands US manufacturing with $19B healthcare investment — ▼ · impact -42 · confidence low · horizon quarters
- · Beta Bionics stock plunges 37% after safety issues emerge — ▼ · impact -40 · confidence low · horizon quarters
- · Amgen shares fall after Novartis' Pelacarsen misses Phase III goal — ▲ · impact +20 · confidence low · horizon quarters